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The  relationship  between  work  rate  (WR)  and  its tolerable  duration  (tLIM) has  not  been investigated  at
high  altitude  (HA).  At  HA  (5050  m)  and  at sea  level  (SL),  six  subjects  therefore  performed  symptom-
limited  cycle-ergometry:  an incremental  test  (IET)  and  three  constant-WR  tests  (%  of IET  WRmax,  HA  and
SL respectively:  WR1 70  ± 8%,  74  ± 7%;  WR2 86  ±  14%,  88 ± 10%;  WR3 105  ± 13%, 104  ±  9%). The  power
asymptote  (CP)  and  curvature  constant  (W′) of  the  hyperbolic  WR–tLIM relationship  were  reduced  at HA
compared  to  SL  (CP:  81  ± 21 vs.  123  ± 38 W; W′: 7.2 ±  2.9 vs. 13.1  ±  4.3 kJ). HA  breathing  reserve  (esti-
mated  maximum  voluntary  ventilation  minus  end-exercise  ventilation)  was  also  compromised  (WR1:
25  ± 25  vs. 50  ±  18  l min−1; WR2: 4  ±  23  vs. 38  ± 23  l  min−1; WR3:  −3 ±  18  vs.  32  ±  24  l min−1) with  near-
maximal  dyspnea  levels  (Borg)  (WR1: 7.2  ± 1.2 vs.  4.8 ±  1.3;  WR2:  8.8  ±  0.8  vs.  5.3 ±  1.2;  WR3: 9.3  ± 1.0
vs.  5.3  ±  1.5).  The  CP reduction  is consistent  with  a  reduced  O2 availability;  that  of  W′ with  reduced
muscle–venous  O2 storage,  exacerbated  by ventilatory  limitation  and  dyspnea.
© 2011 Elsevier B.V. All rights reserved.
1. Introduction
The ability to sustain high-intensity exercise is widely acknowl-
edged to be impaired on acute ascent to high altitude (HA), as
evident in a reduced whole-body maximum O2 uptake (V˙O2  max )
(Hansen et al., 1967) and muscle V˙O2  max (Calbet et al., 2003; Lundby
et al., 2006). This reﬂects, in part at least, a limitation to muscle
O2 delivery and/or utilization rates consequent to the low arterial
O2 content and reductions in maximal cardiac output (Q˙T), stroke
volume (SV) and heart rate (HR) (Vogel et al., 1974) and maximal
muscle blood ﬂow (Q˙M) (Calbet et al., 2003; Lundby et al., 2006).
Furthermore, as the lactate threshold (or gas exchange threshold,
GET) is also reduced at HA, at least acutely (Grassi et al., 1996;
Myers et al., 2008), the metabolic stress associated with a particular
supra-GET work rate (WR) is functionally elevated.
For exercise at sea-level (SL), WRs  that lie immediately above
GET are relatively sustainable as V˙O2 and the elevated blood lactate
and proton concentrations ([L−], [H+]) are each able to stabilize
∗ Corresponding author. Tel.: +39 06 49972057; fax: +39 06 4940421.
E-mail address: valli.gabriele@fastwebnet.it (G. Valli).
(Poole et al., 1988; Whipp, 1994). The upper demarcator of this
“heavy” intensity domain is the “critical power” (CP) (Whipp and
Rossiter, 2005), all higher WRs  being characterized by V˙O2 and
blood [La] and [H+] continuing to increase to, or towards, their max-
imum attainable values (Poole et al., 1988; Whipp, 1994; Jones et al.,
2008). In this “very heavy” (or “severe”): (Jones et al., 2010) inten-
sity domain (Whipp and Rossiter, 2005), the tolerable duration
(tLIM) declines with increasing WR in a fashion that has been well
described by a hyperbolic function both for small muscle groups
(Monod and Scherrer, 1985) and for larger muscle-group exercise
such as cycling (Moritani et al., 1981; Whipp et al., 1982; Poole et al.,
1988):
WR = W
′
tLIM
+ CP (1)
where the curvature constant, termed the anaerobic work capac-
ity (Monod and Scherrer, 1985) or W′ (Whipp et al., 1982; Poole
et al., 1988), is equivalent to a constant amount of work that can
be performed above CP, regardless of the imposed WR  (Moritani
et al., 1981; Whipp et al., 1982; Monod and Scherrer, 1985; Poole
et al., 1988). As CP is generally agreed to represent the highest sus-
tainable WR for which steady states of V˙O2 , blood [L
−] and [H+]
(Poole et al., 1988; Whipp and Rossiter, 2005) and muscle [H+]
1569-9048/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
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(Jones et al., 2008) can be attained, it is assumed to reﬂect a rate of
aerobic energy-pool reconstitution whose magnitude sets the max-
imum WR  that can be sustained without a progressively increasing
anaerobic contribution (Moritani et al., 1981; Poole et al., 1988;
Whipp and Rossiter, 2005; Jones et al., 2010). The constitution of W′
is less certain, but is typically proposed to reﬂect an intramuscular
anaerobic energy store composed of phosphagens such as phospho-
creatine (PCr) and sources linked to anaerobic glycolysis, in addition
to utilization of stored O2. tLIM is reached when this store becomes
depleted, its rate of depletion being proportional to the supra-CP
power requirement (Moritani et al., 1981; Poole et al., 1988). There
could also be an involvement of factors related to the accumulation
of fatigue-related metabolites such as H+, inorganic phosphate (Pi)
and potassium ions (K+) (Fitts, 2008) to some collective “limit” at
a rate proportionally coupled to the rate at which W′ is being uti-
lized (Coats et al., 2003), at which point the WR  can no longer be
sustained (Coats et al., 2003; Poole et al., 1988).
However, little is known about how CP and W′ contribute to
exercise intolerance on ascent to HA, as studies to date have typ-
ically been conﬁned to incremental and/or single constant-WR
protocols, which do not lend themselves to such considerations.
Extrapolating from SL ﬁndings, we propose that a compromised
tLIM at HA is likely to involve a reduction in CP, as CP has been
reported to be decreased at SL when hypoxic gas mixtures are
breathed acutely (Moritani et al., 1981; Whipp et al., 1982). In con-
trast, W′ in these SL studies was unaffected (Moritani et al., 1981;
Whipp et al., 1982). Whether a similar lack of effect for W′ might
be expected at HA is harder to ascertain. Resting and peak exercise
muscle [ATP] and [PCr] levels have been reported to be essentially
unaffected by ascent to HA (van Hall et al., 2009). Likewise, max-
imum blood [L−] has been reported to be similar to SL values on
immediate ascent (despite the lower V˙O2  max ), and although this is
widely reported to decline as acclimatization proceeds (the “lactate
paradox”) (Cerretelli and Samaja, 2003; Reeves et al., 1992; West,
1986), no blunting was evident in arterial [L−], muscle [L−] or leg
net lactate release during incremental exercise for moderate HA
exposure (i.e. two weeks at 4100 m)  compared to acute hypoxia at
SL (van Hall et al., 2009). However, we speculate that a HA-related
reduction in the volume of O2 stored in muscle and venous blood
could cause W′ to be reduced relative to SL values.
It was therefore the purpose of this investigation to evaluate
the effects of acute HA exposure on the parameters of the WR–tLIM
relationship (i.e. CP and W′), as well as key parameters of aerobic
function (i.e. functional V˙O2 gain
(
V˙O2/WR
)
, GET and V˙O2  max )
at an altitude of 5050 m in healthy lowlanders participating in a
trek to the Pyramid Laboratory, near Mount Everest base camp. We
hypothesized that tLIM at a given work rate would be reduced at
HA, consequent to a reduced CP and W′.
2. Methods
2.1. Subjects
Six recreationally active, healthy non-smoking residents (two
females and four males) who were born and permanently resident
at SL (Table 1) provided written informed consent to participate
in the study. The procedures and protocols were approved by the
National Research Council (CNR, Italy) as part of the Ev-K2-CNR
research program, and were conducted in accordance with the Dec-
laration of Helsinki.
2.2. Protocols
The HA phase of the study was conducted at the CNR Pyramid
Laboratory, Lobuche, Khumbu, Nepal (5050 m;  barometric pres-
sure ∼410 Torr) over a 3-day period, and the SL phase 3 months
later (Rome, Italy; ∼100 m).  Timing constraints with relation to the
availability of the HA testing facility precluded the entire SL phase
being performed prior to the HA ascent; however, prior to depar-
ture, each subject completed a single maximal incremental exercise
test. The SL phase was  delayed for 3 months so as to minimize any
effects of acclimatization, with subjects maintaining their pre-HA
activity patterns over this period. The subjects travelled by plane
to Katmandu (1340 m), where they stayed for 4 days before being
ﬂown to Lukla (2860 m)  for a 10-day trek to the Pyramid Labora-
tory with intermediate stops of 3 days at Namche Bazaar (3450 m)
and then 2 days at Pheriche (4252 m) to allow for acclimatization.
During ascent and throughout the stay at the Pyramid Laboratory,
symptoms of acute mountain sickness and resting arterial O2 satu-
ration (SpO2) were monitored. On day 1 at the Pyramid Laboratory,
the subjects rested. On day 2, they performed standard pulmonary
function tests and then completed a familiarization, which included
a maximal incremental exercise test and a resting blood sample
for hematocrit measurement. Standard pulmonary function tests
consisted of three maximal expiratory maneuvers each lasting 6 s,
performed at rest and in the standing position; the best of these
was recorded and utilized for statistical analysis. Calibration of the
spirometer (photoelectric digital turbine, diameter 28 mm;  resolu-
tion 4 ml,  Micro Kit, COSMED, Rome, Italy) was performed prior to
each test, using a 3 l syringe.
On day 3, the formal testing began, with a second maximal
incremental exercise test. On the immediately following days, each
subject completed three high-intensity constant-WR tests to the
limit of tolerance. A recovery period of at least 12 h was  allowed
between tests, so that no subject performed more than two tests
per day and the protocol was completed in 3 days. Just prior to
departing for HA, each subject performed an incremental exercise
test. Three months after returning to SL, all the tests were repeated.
2.2.1. Incremental exercise test
Incremental exercise tests were performed to the limit of tol-
erance from an initial 20 W baseline (at least 4 min), with a WR
incrementation rate of 15 W/min  at HA and 25 W/min  at SL, and
a ﬁnal 20 W recovery (at least 6 min). This allowed determination
of peak V˙O2 (V˙O2  peak ) and V˙O2/WR, and non-invasive estima-
tion of GET using standard and directly validated ventilatory and
pulmonary gas exchange criteria, i.e. the “V-slope” criterion as the
V˙O2 at which a systematic increase in the slope of the CO2 output
(V˙CO2 ) to V˙O2 relationship occurred (Beaver et al., 1973), in con-
junction with the ventilatory equivalent for O2 and end-tidal PO2
starting to increase with no concomitant increase in the ventila-
tory equivalent for CO2
(
V˙E/V˙CO2
)
or decrease in end-tidal PCO2
(e.g. ATS/ACCP, 2003). To allow comparison with CP, the steady-
state WR equivalent of the GET for each condition was  derived by
correcting the measured WR at GET for the inﬂuence of the fun-
damental V˙O2 time constant (
′); i.e. at a given V˙O2 (in this case,
that corresponding to GET), the steady-state WR  equivalent will
be less than the measured WR by an amount equal to the prod-
uct of the ramp WR incrementation rate (W/min) and  ′ (min)
(Whipp, 1994).
2.2.2. Constant-WR test
Constant-WR tests were performed to the limit of tolerance,
again from an initial 20 W baseline (at least 4 min) and with a
ﬁnal 20 W recovery (at least 6 min), each at different WRs  cho-
sen to induce exhaustion over a range of times from ∼2 to 15 min
(e.g. Poole et al., 1988; Whipp, 1994; Jones et al., 2008) and to
provide a relatively even point distribution along the 1/t  axis The
order in which these tests was  imposed was randomized for each
subject.
Author's personal copy
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Table 1
Subject characteristics.
Subject Age (yr) Ht (m)  BMI  (kg m−2) FVC (SL) (l) (% pred) FEV1 (SL) (l) (% pred) HCT (SL) (%) FVC (HA) (l) (% pred) FEV1 (HA) (l) (% pred) HCT (HA) (%)
1 36 1.87 21.6 5.55 (106) 4.17 (108) 44 5.44 (104) 4.57 (94) 58
2  56 1.78 25.6 4.46 (95) 3.33 (98) 40 4.51 (94) 3.02 (96) 50
3 25 1.72 19.6 3.61 (83) 3.14 (90) 43 3.32 (76) 3.25 (93) 40
4  32 1.78 22.7 5.55 (104) 4.92 (117) 44 5.67 (106) 5.2 (124) 60
5 34  1.57 24.3 3.69 (107) 2.95 (108) 38 3.53 (102) 2.67 (98) 55
6  62 1.72 27.7 5.31 (125) 4.09 (136) 42 5.07 (119) 4.01 (133) 50
Mn  ± SD 41 ± 15 1.74 ± 0.10 23.6 ± 2.9 4.70 ± 0.90 (103 ± 14) 3.77 ± 0.75 (109 ± 16) 41.8 ± 2.4 4.59 ± 0.99 (100 ± 14) 3.79 ± 0.98 (106 ± 17) 50.5 ± 7.6*
BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; HCT, hematocrit; SL, sea level; HA, high altitude.
* P < 0.05 vs. SL.
2.3. Equipment
Subjects exercised on a mechanically braked cycle ergometer
(828 E, Monark Exercise AB, Varberg, Sweden), with pedaling fre-
quency being maintained at 60 ± 5 rpm (with subjects following
an electronic audio signal generated each second). Prior to each
test, the zero-load setting on the ergometer was  checked and a
calibration was performed with a 4 kg weight. Ventilatory and pul-
monary gas exchange variables were measured breath-by-breath
in all tests using a portable system (K4b2, COSMED, Italy), which
has previously been used at HA (Pattinson et al., 2004). The sys-
tem comprised a face mask, analyzer unit (containing O2 and
CO2 gas analyzers), heart-rate monitor and battery. The analyzer
unit with battery pack, face-mask and tubing (weight 0.8 kg) was
attached to the subject with a harness and connected to a per-
sonal computer by an Ethernet cable connection. The face-mask
contained a turbine for measurement of volume and ﬂow; cali-
bration was performed with a 3 l syringe (Hans Rudolph, Kansas
City, MO,  USA) over a range of different ﬂow proﬁles. Respired
gas, sampled continuously from a port within the turbine via a
Naﬁon polymer capillary (Permapure©), was analyzed at 100 Hz
using rapid-response O2 (polarographic) and CO2 (infrared) analyz-
ers (mean response time 120 ms); calibration was performed using
two precision-analyzed gas mixtures spanning the respired range.
The gas analyzers were automatically thermostated and compen-
sated for ambient variations in barometric pressure, humidity and
environmental temperature. The volume and gas concentration sig-
nals were sampled and digitized every 10 ms,  and time-aligned;
i.e. correcting for the transport delay between the turbine and gas
analyzers and for the analyzer rise time (Beaver et al., 1973). The
accuracy of the telemetric system has been previously established
(Palange et al., 2000; Pattinson et al., 2004). Heart rate was  calcu-
lated beat-by-beat, and SpO2 was monitored non-invasively using
ﬁnger pulse oximetry (Masimo Rad-5, Masimo Corporation, Irvine,
CA, USA). Capillary blood samples were taken (∼25 l) from the
ﬁnger-tip of the hand, heated by an infrared lamp, at rest, after
2 min  of exercise at 20 W and within the ﬁrst 10 s of recovery (i.e.
end-exercise), and analyzed immediately post-test for [L−] using
an automated analyzer (Lactate-Pro, Arkray, Inc., Japan); calibra-
tion was performed before the analysis of each set of blood samples
using the manufacturer’s calibration strip. Subjects were also asked
to rate “shortness of breath” and “leg effort” at end-exercise in an
alternating sequence using the 0-to-10 Borg category-ratio scale
(Borg, 1982).
2.4. Analyses
Breath-by-breath data were edited to exclude occasional out-
lying breaths (>±4 SD of the local mean), which were the result of
coughs, swallows, sighing or gasping, etc. Baseline V˙O2 for the ini-
tial 20 W warm-up phase was calculated as the mean V˙O2 over the
ﬁnal 60 s. V˙O2  peak was calculated as the average V˙O2 for an integral
number of breaths over the last ∼20 s of the incremental phase. tLIM
was calculated as the interval between the imposition of the WR
step and the point at which the subject could no longer maintain the
required pedaling rate (60 rpm) despite active encouragement from
the same observer. The subjects were not told for how long they
had exercised or at what WR.  CP and W′ were estimated as the WR-
intercept and slope, respectively, by least-squares linear regression
from the WR–tLIM−1 relationship (Poole et al., 1988). Breathing
reserve (BR) was estimated as the difference between the esti-
mated maximum voluntary ventilation (MVV) and the end-exercise
ventilation (V˙Epeak ) (ATS/ACCP, 2003); MVV  being estimated as
FEV1·40 (Campbell, 1982) and FEV1 being measured at SL and
at HA.
Differences among measured responses were determined by
a Student’s paired t-test. Two-way repeated measures anal-
ysis of variance (ANOVA), with a Bonferroni post hoc test,
was used to evaluate differences between variables at each
WR within groups (i.e. HA and SL). Pearson’s Product–Moment
correlation coefﬁcient (R2) was used to identify correlations
between criterion variables. The level of statistical signif-
icance was  set at P < 0.05. Group data are presented as
mean ± SD.
3.  Results
Ascent to HA resulted in a signiﬁcant arterial desaturation at rest
(Tables 2 and 3), SpO2 averaging 83.8 ± 4.6% at HA vs. 97.7 ± 1.0%
at SL (Tables 2 and 3).
3.1. Incremental exercise
The key ﬁndings for incremental exercise (Table 2) are
that at HA, SpO2peak (72.8 ± 7.3 vs. 98.0 ± 1.4%, P < 0.001),
WRpeak (138 ± 26 vs. 208 ± 44 W,  P < 0.01), V˙O2  peak (1690 ± 353
vs. 2227 ± 511 ml  min−1, P < 0.01) and GET (1015 ± 222 vs.
1302 ± 241 ml  min−1, P < 0.01) were each lower compared to SL,
but with no change in V˙O2/WR; it should be noted that these
SL V˙O2  peak values did not differ from those measured in the single
incremental test prior to HA ascent (2221 ± 607 ml  min−1, coefﬁ-
cient of variation: 27.3% vs. 22.9%, respectively pre- and post-HA).
Peak HR was also lower at HA (147 ± 13 vs. 168 ± 12 beat min−1,
P < 0.001), as was peak O2 pulse
(
V˙O2  peak/HR
)
(11.5 ± 2.5 vs.
13.4 ± 3.2 ml  beat−1, P < 0.05). Despite no change in resting blood
[L−] with HA ascent, end-exercise [L−] at HA was appreciably
reduced compared to SL. Despite the lower V˙O2  peak and V˙CO2  peak at
HA, V˙Epeak at HA was  appreciably higher than at SL, as was the slope
of the linear phase of the V˙E − V˙CO2 relationship
(
V˙E/V˙CO2
)
and
V˙E/V˙CO2 at GET, reﬂective of the lower end-tidal PCO2 (PETCO2)
at HA. Consequently, in contrast to SL, the end-exercise breath-
ing reserve (BR) at HA was  not signiﬁcantly higher or lower than
Author's personal copy
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Table 2
Group-mean responses (±SD) to incremental exercise at high altitude and sea level.
High altitude Sea level P-value
V˙O2  peak , ml  min
−1 1690 ± 353 2227 ± 511 0.007
WRpeak, W 138 ± 26 208 ± 44 0.005
GET, ml  min−1 1015 ± 222 1302 ± 241 0.006
V˙O2 /WR, ml  W
−1 10.2 ± 1.2 9.4 ± 0.75 0.2
HRrest, beat min−1 83 ± 18 74 ± 16 0.0003
HRpeak, beat min−1 147 ± 13 168 ± 12 0.0009
O2 pulserest, ml  beat−1 3.7 ± 1.2 3.6 ± 1.6 0.8
O2 pulsepeak, ml  beat−1 11.5 ± 2.5 13.4 ± 3.2 0.05
[La−]rest, mmol  l−1 1.7 ± 0.5 1.9 ± 0.7 0.6
[La−]peak, mmol l−1 5.8 ± 1.7 9.5 ± 3.0 0.03
V˙CO2  peak , ml  min
−1 2059 ± 573 2816 ± 780 0.02
RERpeak 1.21 ± 0.13 1.26 ± 0.18 0.6
V˙Epeak , l min
−1 121 ± 35 94 ± 30 0.07
BR,  l min−1 31 ± 28 57 ± 20 0.1
fRpeak 51.2 ± 7.9 38.5 ± 6.6 0.04
V˙E/V˙CO2 44 ± 5 24 ± 2 0.0001
V˙E/V˙CO2 at GET 45 ± 4 29 ± 2 0.000009
PETCO2rest, mm  Hg 25 ± 1 33 ± 3 0.0003
PETCO2peak, mm Hg 20 ± 2 37 ± 2 0.00003
SpO2rest, % 85.0 ± 4.3 97.7 0.0009
SpO2peak, % 73 ± 7 98 ± 2 0.0005
Dyspnea 9.3 ± 1.0 5.3 ± 1.8 0.005
Leg  fatigue 7.8 ± 1.5 9.2 ± 0.8 0.2
V˙O2 , O2 uptake; WR,  work rate; GET, gas exchange threshold; HR, heart rate; [La
−],
lactate concentration; V˙CO2 , CO2 output; RER, respiratory exchange ratio; V˙E, venti-
lation; PETCO2, end-tidal PCO2; SpO2, arterial O2 saturation.
the estimated limiting value of 0 (P = 0.19; 2-tailed paired t-test).
In addition, the end-exercise dyspnea at HA was greater than for
SL, attaining the limiting value of 10 (P = 0.17; 2-tailed paired t-
test). Leg fatigue was slightly reduced at HA, although this was not
statistically signiﬁcant.
3.2. Constant-WR exercise
For each subject, 1/tLIM was directly correlated with WR  both at
SL and HA, and the data were well ﬁt to a linear regression of WR
vs. tLIM−1 (Fig. 1), with R2 values typically being at least 0.98, and
the mean SE of the CP estimation being 5 W.  However, CP and W′
were signiﬁcantly reduced at HA compared to SL (CP: 81 ± 21 vs.
123 ± 38 W,  P = 0.04; W′: 7.2 ± 2.9 vs. 13.1 ± 4.3 kJ, P = 0.02).
The constraints placed on WR  selection for the constant-
WR tests (i.e. with tLIM falling in the range ∼2–15 min: see
Section 2) resulted in the absolute WRs  at HA being apprecia-
bly lower than those at SL (Table 3). This precluded iso-WR
comparisons of response. However, in all subjects, end-exercise
V˙O2 met  the criterion for V˙O2  max by being independent of WR
(Fig. 2, Table 3), averaging 1583 ± 358 ml  min−1 at HA and
2232 ± 520 ml  min−1 at SL, which was  not signiﬁcantly differ-
ent from the corresponding V˙O2  peak obtained on the incremental
test (Table 2). As was  the case for the incremental tests, end-
exercise SpO2 was lower at HA (averaging 73.3 ± 6.4 vs. 97.6 ± 1.0%,
P < 0.00001), end-exercise HR was  lower (averaging 148 ± 14 vs.
168 ± 12 beat min−1, P < 0.0002) as was end-exercise O2 pulse
(11 ± 2 vs. 13 ± 3 ml  beat−1, P < 0.00002) (Table 3). End-exercise [L−]
was signiﬁcantly reduced at HA (7.5 ± 2.5 mmol vs. 9.7 ± 2.1 mmol,
respectively; P < 0.001), although independent of WR (Table 3) and
not signiﬁcantly different from the corresponding values at the
limit of tolerance on the corresponding incremental test (Table 2).
As was  the case for the incremental tests, end-exercise V˙E at
HA was  higher than at SL, averaging 143 ± 41 vs. 111 ± 23 l min−1
(P < 0.001), respectively, despite the applied WRs  at HA being less
than at SL (Table 3, Fig. 3). Also, end-exercise V˙E for the individ-
ual constant-WR tests was  greater the higher the WR at HA and
also at SL (Table 3, Fig. 3). However, FEV1 and therefore MVV  at
HA were not signiﬁcantly changed on average (Table 1), although
increases were evident in some subjects and decreases in others
consistent with the variable responses reported in the literature
(Mansell et al., 1980; Gautier et al., 1982; Welsh et al., 1993). Con-
sequently, the reduction in breathing reserve was more marked as
WR increased (Table 3, Fig. 3) and, in contrast to SL, attained the
estimated limiting value of 0 at HA (P = 0.015, 0.33 and 0.34 for
WR1, WR2 and WR3, respectively). Similarly, dyspnea at HA was
progressively exacerbated with increasing WR,  also attaining max-
imal values at WR3 (P = 0.0001, 0.006 and 0.02 for WR1, WR2 and
WR3, respectively). In contrast, leg fatigue was  signiﬁcantly lower
at HA, averaging 5.5 ± 1.2 vs. 7.6 ± 0.9 (P < 0.00008).
Both at SL and HA, CP was correlated with GET, expressed as
the steady-state WR-equivalent of the V˙O2 value at GET (R
2 = 0.68,
P < 0.05 and 0.76, P < 0.05, respectively). Furthermore, the individ-
ual reductions in CP at HA, relative to SL, correlated with the
corresponding reductions in GET, expressed as the steady-state
WR-equivalent of the V˙O2 value at GET (R
2 = 0.77, P < 0.05), with the
Table 3
Group-mean end-exercise responses (±SD) to exhausting constant-load exercise at high altitude and sea level.
High altitude Sea level
WR1 WR2 WR3 WR1 WR2 WR3
WR,  W 99 ± 24 114 ± 25* 142 ± 26*,# 152 ± 37§ 175 ± 44*,§ 208 ± 48*,#,§
WR,  % WRpeak 72 ± 13 83 ± 14* 104 ± 13* 73 ± 6 83 ± 6* 100 ± 5*
tLIM, s 378 ± 142 242 ± 59* 117 ± 22*,# 523 ± 198 249 ± 30* 156 ± 20*,#
V˙O2 , ml  min
−1 1548 ± 370 1651 ± 382 1550 ± 380 2280 ± 587§ 2227 ± 540§ 2189 ± 527§
HR, beat min−1 148 ± 17 150 ± 14 147 ± 12 169 ± 12§ 169 ± 10§ 165 ± 16§
O2 pulse, ml beat−1 10 ± 2 11 ± 3 11 ± 2 14 ± 4† 13 ± 4† 13 ± 4†
[La−], mmol  l−1 6.2 ± 1.8 7.1 ± 1.7 9.1 ± 3.1 10.7 ± 2.2 § 9.9 ± 1.9 § 8.4 ± 1.7
V˙CO2 , ml  min
−1 1888 ± 404 2170 ± 567 2134 ± 514 2382 ± 505 2747 ± 657*,§ 2932 ± 732*,#,§
RER 1.23 ± 0.19 1.32 ± 0.14* 1.38 ± 0.03* 1.06 ± 0.7 1.24 ± 0.08* 1.34 ± 0.04*
V˙E, l min−1 126 ± 49 147 ± 42 155 ± 32* 101 ± 17§ 113 ± 22§ 119 ± 29§
BR, l min−1 25 ± 25 4 ± 23 −3 ± 18 50 ± 18§ 38 ± 23§ 32 ± 24§
V˙E/V˙CO2 66 ± 14 68 ± 7 73 ± 9 43 ± 7§ 42 ± 5§ 41 ± 7§
PETCO2, mm Hg 20 ± 3 20 ± 2 20 ± 2 31 ± 2§ 34 ± 5§ 35 ± 5§
SpO2rest, % 82.7 ± 5.1 84.0 ± 6.0 83.5 ± 3.9 97.2 ± 0.8§ 98.2 ± 1.2§ 97.7 ± 0.5§
SpO2peak, % 71 ± 6 74 ± 8 75 ± 5 98 ± 1§ 97 ± 1§ 98 ± 2§
Dyspnea 7.2 ± 1.2 8.8 ± 1.2* 9.3 ± 1.0* 4.8 ± 1.3§ 5.3 ± 1.2§ 5.3 ± 1.5§
Leg fatigue 6.0 ± 1.3 5.2 ± 1.2 5.3 ± 1.0 7.7 ± 0.8† 7.2 ± 0.8† 7.8 ± 1.0†
* P < 0.05 vs. WR1.
# P < 0.05 vs. WR2.
§ P < 0.01 vs. HA.
† P < 0.05 vs. HA.
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Fig. 1. Individual WR–tLIM (above) and WR–tLIM−1 (below) relationships for all subjects at sea level (open symbols, thin text) and high altitude (closed symbols, bold text).
Linear regression on the WR–tLIM−1 relationship yields CP (y-intercept) and W′ (slope).
linear regression of CP on GET having a slope not signiﬁcantly
different from unity (1.134 ± 0.251; P = 0.011) and a CP-intercept
not signiﬁcantly different from zero (−1.25 ± 11.2; P = 0.916) (Fig. 4,
left panel). In contrast, there was no correlation between the cor-
responding reductions in W′ and those of GET (Fig. 4, right panel).
4. Discussion
In this ﬁrst study to characterize the power–duration (WR–tLIM)
relationship for high-intensity constant-WR exercise following
ascent to HA (5050 m)  in lowlanders (sufﬁcient to lower SpO2 at
end-exercise to slightly above 70%: Tables 2 and 3), we demon-
strated the relationship to be well-described by a hyperbolic
function after 14 days at HA, as has been extensively documented at
SL. The impaired exercise tolerance at HA in this intensity domain
was the result of reductions in the associated parameters, CP and
W′.
4.1. Decreased critical power
Our demonstration of a reduced CP on ascent to HA, in conjunc-
tion with reductions in V˙O2 max , GET, and peak O2 pulse (Figs. 1 and 2;
Tables 2 and 3) is consistent with CP reﬂecting a limiting rate of
aerobic energy-pool reconstitution (Moritani et al., 1981; Whipp
et al., 1982; Poole et al., 1988), and coheres with the effects of acute
hypoxic exposures at SL (Moritani et al., 1981; Whipp et al., 1982).
Further support for this view is that CP was highly correlated with
L both at SL and at HA - although it should be noted that valida-
tion of the non-invasive GET estimation against directly-measured
arterial [L−] at HA has not yet formally been undertaken. Indeed,
the HA-related reduction in CP was essentially equal to that of the
WR-equivalent of GET. The likely cause of the reduced CP would
therefore seem to favor a reduced O2 availability to and/or utiliza-
tion by the exercising muscles, rather than impaired pulmonary
gas exchange. For example, while acute simulated HA exposures of
similar equivalent height to the present study have been reported
to result in a widened alveolar-to-arterial PO2 difference during
exercise consequent to increased ventilation–perfusion inequal-
ity and diffusion limitation (e.g. Wagner et al., 1986), later studies
following a 2-week altitude exposure at 3800 m arrived at rather
different conclusions. The period of acclimatization returned the
alveolar-to-arterial PO2 difference to SL values (Bebout et al., 1989)
which, as Q˙T at a given V˙O2 was  lower at HA, was  proposed to reﬂect
the inﬂuence of a longer pulmonary capillary vascular transit time;
ventilation–perfusion status was unchanged, however.
With regard to the possibility of impaired convective O2
transport into the exercising muscles, arterial O2 delivery and
mean muscle end-capillary PO2 at maximal exercise have been
reported to be reduced following a 2-week HA exposure at 4100 m,
although no submaximal responses were measured (Lundby et al.,
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Fig. 2. V˙O2 , HR and O2 pulse response proﬁles for a representative subject for three constant-WR tests performed to the limit of tolerance at sea level (open symbols) and
high  altitude (closed symbols) from unloaded pedaling. The vertical dashed line indicates exercise onset. IET indicates V˙O2  peak from ramp tests. WR1: 185 W (square); WR2:
205  W (triangle); WR3: 225 W (circle).
Fig. 3. Left panel: V˙E response proﬁles for a representative subject for three constant-WR tests performed to the limit of tolerance at sea level (open symbols) and high
altitude (closed symbols) from unloaded pedaling. The vertical dashed line indicates exercise onset. Center and right panels: Group-mean end-exercise responses for V˙E and
dyspnea  for the three constant-WR tests (WR1, WR2 and WR3).
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Fig. 4. Left panel: individual reductions in CP at HA, relative to SL (CP(SL-HA)) as a function of the corresponding individual reductions in GET at HA (GET (SL-HA)). Right
panel:  individual reductions in W′ at HA, relative to SL (W′(SL-HA)) as a function of the corresponding Individual reductions in GET at HA (GET (SL-HA)). Lines are best-ﬁt
linear  regressions.
2006). And, in our study, the already-low resting SpO2 fell fur-
ther throughout both the incremental and the constant-WR tests
(Tables 2 and 3). The HA-related increase in hematocrit that we
observed was presumably consequent to plasma volume decline
and possibly also an increasing red cell mass (although the lat-
ter is generally agreed to be of far slower onset), coupled with
hypoxia-induced hyperventilation (Tables 1–3,  Fig. 3). This would
be expected to provide some measure of compensation for the ini-
tially reduced arterial O2 content (CaO2) (reviewed in Grover et al.,
1986; Schoene, 2000). However, this could well have been offset
by a lower Q˙T and Q˙M at the HA CP, compared to the SL CP, because
of the lower WR  and presumably V˙O2 . For example, Q˙T at a given
submaximal WR  (or V˙O2) has been shown to be lower at HA (after
10 days at 4350 m)  than at SL, largely consequent to a reduced SV
despite HR still tending to be slightly elevated (Vogel et al., 1974)
(our demonstration of a reduced peak HR is consistent with this:
Tables 2 and 3, Fig. 2); it is only at substantially higher altitudes
that the submaximal Q˙T − V˙O2 relationship returns to the SL char-
acteristic (Reeves, 2002). Also, a smaller fraction of Q˙T appears to
be preferentially distributed to the working muscles at HA than at
SL (Calbet et al., 2003) which, interestingly, might reﬂect greater
perfusion demands of the respiratory muscles at HA because of the
higher V˙E’s (Table 3; Fig. 3) (Dempsey et al., 2006). Finally, Lundby et
al. (2004) have demonstrated no increase in the expression of either
hypoxia inducible factor 1a or vascular endothelial growth factor
mRNA in muscle after 2 week at a similar altitude to our inves-
tigation, and no increase in capillary-to-muscle ﬁbre ratio after 8
week.
We therefore speculate that Q˙M at CP was lower at HA than at SL
and therefore that arterial O2 delivery was also lower. However, we
were unable to incorporate these technically demanding measure-
ments into constant-WR tests at CP in order to test this proposal.
How muscle mitochondrial PO2 at CP is affected by the HA ascent
also can only speculated upon. It has been argued, from studies at
a slightly lower altitude (4100 m)  than the present study (Wagner
et al., 1986; Lundby et al., 2006), that O2 diffusive conductance may
be more important than convective O2 transport in limiting maxi-
mal  performance; whether this is also the case at CP, with its lower
V˙O2 , can only be speculated on. Regardless, it seems unlikely that
oxidative enzyme activities are affected (Young et al., 1984; Mizuno
et al., 2008).
It is of interest that the fundamental (or phase II) kinetics of
the V˙O2 response to constant-WR exercise has been reported to be
slowed with acute normobaric hypoxia below GET (Murphy et al.,
1989) and above GET (Engelen et al., 1986). Were this to occur also
at HA, it would imply an increase in the magnitude of the O2 deﬁcit
at a given WR,  and, depending on how the “slow component” of the
V˙O2 response were to be inﬂuenced by the HA exposure, this would
have the potential to constrain the range of WRs  that could be
accommodated by the limiting aerobic energy-pool reconstitution
rate without incurring a progressively increasing anaerobic contri-
bution (Moritani et al., 1981; Whipp et al., 1982; Poole et al., 1988).
However, the single constant-WR transitions used in the present
study precluded any formal kinetic analysis of the V˙O2 responses,
because of sub-optimal signal:noise considerations compounded
by complexities related to the inﬂuence of the V˙O2 slow component
and the exact value of the asymptotic V˙O2 value at these supra-CP
WRs  (Whipp and Rossiter, 2005).
4.2. Decreased W′
Our demonstration of a reduced W′ at HA (Fig. 1) is at odds
with the effects of acute hypoxic exposures at SL (Moritani et al.,
1981; Whipp et al., 1982), which suggest that some sequellae
related to acclimatization may be involved which would not be
evident with acute hypoxia at SL. With regard to anaerobic energy
stores, it is likely that O2 stores (e.g. in muscle and venous blood)
were lower at HA consequent to the hypoxic conditions, although
we were not able to quantify this. As muscle–venous O2 con-
tent (Cv,MO2) changes can reasonably be assumed to dominate
the “anaerobic” O2 stores, the stores contribution to W′ can be
viewed as the extent to which these stores become depleted above
CP: i.e. the difference between the product of Cv,MO2 and the
effective muscle–venous volume at CP and at maximal exercise
(all supra-CP WRs  leading to V˙O2  max ). The study of Lundby et al.
(2006) provides some insight in this context: from their primary
V˙O2 , Q˙M and arterial O2 delivery data, it is evident that Cv,MO2 at
maximal exercise is lower at HA than at SL (∼1.5 ml  100 ml−1 vs.
∼2.0 ml  100 ml−1). Even were simplifying assumptions to be made
regarding the effective venous volume, the lack of information
about the corresponding Cv,MO2 values at CP hinders any further
analysis, however.
In contrast, muscle glycogen stores and their breakdown during
exhausting exercise are not compromised for comparable HA expo-
sures (van Hall et al., 2009); neither is the activity of key glycolytic
enzymes (hexokinase, glycogen phosphorylase) affected (Young
et al., 1984). Similarly, intramuscular PCr stores have been reported
to be depleted to a similar extent for exhaustive exercise at HA as at
SL (van Hall et al., 2009). However, were the associated V˙O2 kinetics
to be slower (see above), this suggests (based on 31P-NMR measure-
ments) a correspondingly slowed time-course of [PCr] depletion
and therefore a more marked [PCr] fall (Rossiter et al., 2002); a
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contention which is supported by the observations of Haseler et al.
(1998) for normobaric hypoxic plantar ﬂexion exercise.
An involvement of fatigue-related metabolite accumulation
should also be considered. Muscle [Pi] during exhausting exercise at
HA has been reported to be no different from SL, for short-duration
exposures (van Hall et al., 2009). However, interpreting the conse-
quences of the lower end-exercise arterial [L−] (e.g. Tables 2 and 3)
(Reeves et al., 1992; but c.f. van Hall et al., 2009) and muscle [L−]
at HA (Brooks et al., 1998; but c.f. ref. van Hall et al., 2009) is chal-
lenging for considerations of W′. That is, it has been demonstrated
that, for submaximal exercise following ascent to HA (as at SL),
exercising muscles simultaneously produce and oxidise L−, with a
reduced L− clearance suggesting that other tissues contribute to the
elevated arterial [L−] (Brooks et al., 1998). Whether this is the case
also for fatiguing exercise has not, to our knowledge, been explored.
The consequences for H+ status in our study are also largely
uncertain. Although the respiratory alkalosis that develops on
immediate HA ascent (e.g. Tables 2 and 3) would be expected
to temper the deleterious consequences of developing acidosis
in the exercising muscles, subsequent renal compensation com-
promises the bicarbonate-related buffer capacity (Cerretelli and
Samaja, 2003). However, the extent to which whole-body buffer
capacity might be affected in our study is uncertain.
One factor that has the potential to inﬂuence W′ at HA is
exercising-muscle mass, a signiﬁcant correlation having been
reported between W′ for cycle ergometry and thigh circumference
(Miura et al., 2002). A further factor relates to muscle activation. It
has been reported that Group III and IV muscle ﬁber discharge is
reduced in experimental animals, both in acute and chronic hypoxia
(e.g. Dousset et al., 2003). Others, however, have argued for an
increase (e.g. Hill et al., 1992; Amann and Kayser, 2009). The extent
to which such inﬂuences might impact on W′ (or CP) is unclear,
however.
Altitude exposure is well known to lead to weight loss, con-
sequent to factors such as loss of appetite, loss of body water,
increased basal metabolic rate, increased activity levels and sar-
copenia. However, as our subjects showed no reduction in body
mass at HA (70.8 ± 10.7 kg vs. 69.7 ± 11.5 kg at SL), it seems unlikely
that an altitude-related loss of exercising-muscle mass is a signiﬁ-
cant contributor to the reduced W′.
A component of central fatigue is possible, however. That is,
for comparable HA exposures, exercise tolerance was  improved by
breathing hyperoxic inspirates; an effect that was considered to
be related to the improved cerebral reoxygenation (reviewed in
Amann and Kayser, 2009).
4.3. Ventilatory limitation and dyspneic sensation
What is evident from our study is that V˙Epeak for both the incre-
mental and constant-WR tests at HA was likely to be contributing
to the limitation, i.e. with little or no breathing reserve remaining,
such that tLIM at a given supra-CP WR  was prematurely truncated.
This clearly contrasted with the SL ﬁndings (Tables 2 and 3; Fig. 3).
Arterial hypoxemia, acting at the carotid chemoreceptors, is likely
to be a major contributor to the exaggerated V˙E responses we
observed at HA. This raises the issue that a signiﬁcant contributor
to exercise intolerance above CP could be the associated intensity
of dyspneic sensation, which in contrast to leg fatigue, attained
limiting values at HA (Tables 2 and 3; Fig. 3). In this context, obser-
vations from the 2004 Everest-K2 Italian Expedition are of interest.
That is, those climbers who reached the summit without oxygen
evidenced a lower resting V˙E and hypoxic ventilatory responsive-
ness (HVR, V˙E − SpO2) during acclimatization (Bernardi et al.,
2006); it being proposed that a less sensitive HVR at HA might
increase BR and therefore reduce dyspnea to allow sustainable V˙E’s
in the extreme hypoxia at the summit. It should be noted that
the observations of Bernardi and coworkers are in contrast those
of Schoene et al. (1984) who  observed a better climbing perfor-
mance in those subjects with a higher HVR at HA. However, the
techniques used for estimating HVR at HA in these two  studies
were different: Schoene et al. using Dejours-type transient N2 and
O2 tests, while Bernardi et al. used the more traditional progres-
sive isocapnic hypoxia approach. The Dejours approach is designed,
because of its transient nature, to “isolate” the primary peripheral
chemoreceptor component of the hypoxic V˙E response, whereas
the sustained progressive exposure allows time for additional inﬂu-
ences of the altered PO2 on V˙E to be expressed (e.g. CNS actions on
pH via the hemoglobin dissociation curve and cerebral blood ﬂow)
(for discussion, see Ward, 1994). A further point to be considered is
that the “high performing” subjects studied by Bernardi et al. also
evidenced a slow, deep pattern of breathing which could have con-
tributed to the reported improvement in pulmonary gas exchange
efﬁciency in these subjects. Even so, there is not a ready explanation
for the observed differences. The factors contributing to the dysp-
nea at HA are likely to be complex, however, involving also factors
such as respiratory work and respiratory muscle fatigue (CiIbella
et al., 1995) and an amplifying effect of the hypoxic condition (Ward
and Whipp, 1989).
Finally, there may  also be a contribution to the compromised
exercise tolerance above CP at HA, consequent to the possibility that
the demands of the respiratory muscles at these high WRs  diverted
a proportion of the perfusion away from the involved locomotor
muscles (Calbet et al., 2003), predisposing to locomotor muscle
fatigue (reviewed in Dempsey et al., 2006). End-exercise V˙E clearly
encroached on BR, implying respiratory ﬂow limitation (Table 3;
Fig. 3).
4.4. Conclusion
The reduction in CP on acute ascent to HA (5050 m)  is consistent
with a reduced O2 availability to the exercising muscle. In contrast,
the associated reduction of W′ is less easily explained, but could
be the consequence, at least in part, of reduced muscle–venous O2
storage and limiting levels of dyspnea consequent to ventilatory
limitation.
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